Find Academic Supervisors

S.E. FreemanView profile

Research Fellow

• Political Economies
• Racial Geographies
• Critical Environments
• +7 more

S.E. Freeman is a Research Fellow at Wesleyan University's Center for the Humanities (Fall 2024) and a PhD Candidate (ABD) in Geography at UC Berkeley with a Designated Emphasis in Science and Technology Studies. Their research explores categorization practices in humanitarian contexts, particularly how displacement is quantified through biometrics and geospatial technologies in South Sudan. This work interrogates the epistemological hierarchies shaping humanitarian interventions in an era of digital mobility. Education includes an M.A. in Anthropology from The New School for Social Research and a B.A. in Sociology and International Studies from Northwestern University. Freeman has held extensive fellowships, including the 2024 Charlotte W. Newcombe Fellowship and 2022 Social Science Research Council International Dissertation Research Fellowship. Research interests span political economies, racial geographies, and critical environments, with a focus on quantification, surveillance, and colonial legacies. Their work integrates queer and feminist STS frameworks to critique humanitarian data practices. Teaching experience includes roles as a Graduate Student Instructor in Geography courses at UC Berkeley (2020). Awards also include the 2021 Outstanding Graduate Student Instructor Award and multiple pre-dissertation fellowships from UC Berkeley's Center for African Studies. Awards highlight recognition for interdisciplinary scholarship, including the 2021 Wenner-Gren Dissertation Grant and 2018 Regents Fellowship. Their research bridges critical geography, science studies, and postcolonial theory to examine how technologies of measurement shape lives deemed 'worthy of saving' in global humanitarianism.

• Pharmacology
• Physiology
• Cardiovascular Disease
• +5 more

Sumangali Wijetunge is a Senior Lecturer in Pharmacology at the Department of Chemical and Pharmaceutical Sciences , part of the School of Life Sciences, Pharmacy and Chemistry at Kingston University . She serves as Admissions Tutor and module leader for the Systems Pharmacology module (LS5010) at Level 5. Prior to joining Kingston University in December 2014, she spent over 20 years at Imperial College London as a Postdoctoral Research Fellow and Research Lecturer. BSc (Hons) in Pharmacology from University College London PhD in Pharmacology from Imperial College London (1998) Fellow of the Higher Education Academy (2017) Her research focuses on two primary areas: Cardiovascular disease mechanisms linked to lifestyle factors Pedagogical investigations into university student performance Her scientific work examines vascular calcium channel regulation by tyrosine kinases, with recent publications exploring retinal microvascular abnormalities as indicators of cerebrovascular disease. Scientific contributions span pharmacology, physiology, and biomedical education. Publications in journals like Stroke and Microcirculation demonstrate cross-disciplinary impact in cardiovascular research and developmental medicine. Scientific Recognition Fellow of the Higher Education Academy She actively contributes to teaching across multiple programs including Biological Sciences, Biomedical Science, and Pharmacology, while maintaining research collaborations involving clinical and experimental studies of vascular function.

• Ophthalmology
• Retinal Microvasculature
• Optical Imaging Techniques
• +3 more

Paula Yu is a Research Associate Professor affiliated with the UWA Medical School and the Centre for Ophthalmology and Visual Science at The University of Western Australia. Her primary focus is on retinal microvascular physiology, neurovascular coupling, and advanced imaging techniques such as optical coherence tomography (OCT) and confocal microscopy. She holds a position at the Lions Eye Institute, further emphasizing her clinical and research contributions to ophthalmology. Her research interests center on understanding microvascular hemodynamics, endothelial cell function, and the structural basis of retinal vascular diseases. Key projects include studies on retinal vein contraction mechanisms, lymphatic imaging, and the application of deep learning in clinical ophthalmology. Her work bridges basic science and translational medicine, with implications for glaucoma, diabetic retinopathy, and vascular comorbidities. Recent publications highlight innovations in label-free imaging techniques and quantitative analyses of capillary networks. She has contributed to datasets on spatial-temporal perfusion variations and collaborated on grants related to OCT systems and retinal vein occlusion treatments. Her interdisciplinary approach integrates engineering, biology, and clinical insights to advance diagnostic and therapeutic strategies in ophthalmology. Paula Yu has secured funding from the NHMRC and Ophthalmic Research Institute of Australia for projects involving imaging technology development and clinical trials. She leads or participates in collaborative initiatives that address critical questions in retinal vascular biology and disease mechanisms.

• Ophthalmology
• Visual Science
• Retinal Research
• +4 more

Stephen Cringle is a Professor at the UWA Medical School , affiliated with the Lions Eye Institute and based in the Centre for Ophthalmology and Visual Science . His research focuses on retinal vascular dynamics, intraocular pressure, and biomedical engineering applications in ophthalmology. Institution: The University of Western Australia Key Collaborations: Yu, D.Y., Morgan, W.H., Balaratnasingam, C. His work explores capillary hemodynamics , endothelial cell behavior , and vascular interactions in ocular health, with applications in retinal ischemia and glaucoma treatments. Recent studies analyze spatial-temporal perfusion patterns in retinal networks, pressure dynamics across anatomical regions, and laser photocoagulation therapy optimization. Stephen has secured significant grants from the NHMRC and National Institutes of Health for projects like developing novel glaucoma surgeries and improving retinal oxygenation. His lab collaborates on in vivo imaging and vascular modeling using advanced techniques such as confocal microscopy and OCT systems.

• Ocular Pharmacology
• Endocannabinoid System Research
• Neurodegenerative Diseases
• +3 more

Dr. Melanie Kelly is a Professor in the Departments of Pharmacology, Ophthalmology & Visual Sciences, and Anesthesia, Pain Management & Perioperative Medicine at Dalhousie University, Halifax, Canada. She holds additional roles as Executive Director of the International Cannabinoid Research Society and Chief Scientific Officer at Panag Pharma Inc. Her research focuses on the pharmacology of the endocannabinoid system, particularly its role in ocular and central nervous system diseases. Her laboratory, the Kelly Lab, is part of the Retina and Optic Nerve Research Laboratory within the Faculty of Medicine. Key research areas include cannabinoid receptor function in ocular inflammation, regulation of intraocular pressure, and translational drug development for neurodegenerative diseases and pain management. Dr. Kelly has authored over 100 publications and holds several patents in cannabinoid drug development. She collaborates extensively with institutions globally and contributes to education and professional training in medicine and pharmacy.

• Ophthalmology
• Epidemiology
• Child Growth
• +7 more

Olta Gishti is a researcher in the Department of Ophthalmology at Erasmus MC, Faculty of Medicine, Netherlands. Her work is primarily embedded within the Generation R Study, a large prospective population-based cohort investigating early-life determinants of health and disease. She collaborates extensively across disciplines including epidemiology, pediatrics, obstetrics, and neonatology. Her research focuses on the developmental origins of health and disease, particularly how maternal factors during pregnancy influence child growth, cardiovascular risk, and ocular outcomes. Key areas include retinal vessel development, infant growth patterns, and the long-term impacts of breastfeeding and maternal conditions like vomiting and hypertension. Ophthalmology and retinal microvascular health in children Maternal and perinatal epidemiology Child growth and adiposity Cardiovascular risk programming Posterior vitreous detachment and retinal pathology The recent publications show a strong trend in using epidemiological methods to link prenatal exposures with pediatric and adolescent health outcomes, especially through objective measures like retinal imaging and anthropometric data. Much of her work leverages the rich dataset of the Generation R Study to uncover associations with clinical and public health implications. While no formal scientific awards are listed in the provided text, her publications have been cited over 100 times collectively and have influenced policy and media discourse. Her research has been referenced in policy sources and picked up by news outlets, indicating societal impact. Dr. Gishti has contributed to mentoring and collaborative research within multidisciplinary teams at Erasmus MC. Though no direct advisees are named, her role in major studies suggests involvement in training junior researchers and contributing to grant-funded projects such as those under research programs EMC COEUR-09, EMC MGC-02-52-01-A, and others. She is part of a robust research network in ophthalmology and developmental epidemiology, working closely with leading scientists in maternal-fetal medicine and pediatric health. Her work continues to bridge clinical ophthalmology with population health, aiming to identify early biomarkers of disease and improve long-term outcomes.

• Diabetic Retinopathy
• Microvascular Dysfunction
• Vascular Endothelial Growth Factor (VEGF)
• +7 more

Nikita Ved is a Research Professor at the Department of Physiology, Anatomy and Genetics, University of Oxford, affiliated with Merton College. They work in Prof Paterson's group, focusing on diabetic microvascular complications and vaccine uptake disparities in British Indian communities. Education: Undergraduate in Neuroscience, University of Bristol PhD in Ophthalmology, University College London (2016) Research Interests: Nikita Ved investigates diabetic retinopathy and neuropathy, emphasizing VEGF splice variants. Additional work examines maternal diabetes effects on embryonic heart defects and health inequalities in ethnic minorities. Scientific Awards: MBE (2023) for vaccine advocacy STEM for Britain Finalist (2019) European Society of Cardiology Prize (2018) British Microcirculation Society Young Investigator’s Prize (2015) Advising & Grants: They received a Novo Nordisk Postdoctoral Fellowship (2016) and co-founded the 1928 Institute (2020) to address vaccine misinformation in the British Indian community. Outreach: Nikita Ved is a key organizer for Pint of Science, British Science Association, and House of Commons science policy events, bridging public and academic discourse.

• Vascular Biology
• Angiogenesis
• VEGF Signaling
• +5 more

David O. Bates is Professor of Vascular Biology in the Cancer Biology, Division of Cancer and Stem Cells at the University of Nottingham's School of Medicine. His research focuses on vascular endothelial growth factors (VEGF), particularly their alternative splicing mechanisms and roles in physiological regulation and disease processes. Professor Bates' work spans multiple disciplines including vascular biology, cancer research, and diabetic complications. His laboratory investigates how VEGF splicing variants, particularly the anti-angiogenic VEGF-A 165 b isoform, function as homeostatic regulators in healthy tissues. His team has demonstrated VEGF's critical roles in maintaining blood volume and pressure, interstitial volume, renal and lung function, immunity, and nervous system signaling. Current research examines how dysregulation of VEGF splicing contributes to pathological conditions including cancer, diabetic retinopathy, neuropathic pain, and vascular permeability disorders. Analysis of Professor Bates' recent publications reveals a strong emphasis on therapeutic targeting of the SRPK1-VEGF-A splicing pathway. His work spans from basic molecular mechanisms of alternative splicing to translational applications in diabetic eye disease, peripheral vascular disease, and arthritis. Several of his recent studies focus on developing topical treatments for diabetic macular edema with high retinal bioavailability and minimal systemic exposure. Professor Bates has made significant contributions to understanding the physiological roles of VEGF beyond its well-known angiogenic functions. His work has demonstrated VEGF's homeostatic functions in healthy adult tissues and how disturbances in VEGF signaling contribute to disease processes. This research has important implications for developing targeted therapies that preserve VEGF's beneficial homeostatic functions while inhibiting its pathological effects. His research program includes collaborations across multiple institutions and disciplines, reflecting the broad relevance of VEGF biology to numerous physiological systems and disease processes. Professor Bates serves as a corresponding author on numerous high-impact publications and continues to advance our understanding of vascular biology through innovative research approaches.

• Cardiovascular Research
• Molecular Imaging
• Tissue Engineering
• +2 more

Prof. Marc van Zandvoort is a Professor at the Institute for Molecular Cardiovascular Research (IMCAR), specializing in advanced microscopy applications for cardiovascular and tissue engineering research. His work bridges molecular imaging, cellular dynamics, and clinical pathology through interdisciplinary collaborations. His primary research focuses on cardiovascular microvasculature, tissue engineering maturation, and cellular death mechanisms. He employs multiphoton microscopy, two-photon endoscopy, and super-resolution techniques to investigate placental pathologies in preeclampsia, atherosclerotic plaque microvasculature, mitochondrial networks, and cerebrovascular glycocalyx integrity. Key methodologies include quantitative imaging of nuclear morphology, 3D structural analysis, and biomaterial characterization for drug delivery systems. Analysis of his 2023-2025 publications reveals dominant themes in cardiovascular imaging (68%), placental/obstetric research (20%), and neural applications (12%). Technical innovations center on multiphoton imaging for tissue engineering maturation (32%), hydrogel-based biomaterials (24%), and mitochondrial dynamics in cell death pathways (16%), with strong cross-disciplinary links to obstetrics, cardiology, and nanomedicine. Scientific Awards: None mentioned in the provided text. Information on student advising, research grants, and educational background was not provided in the available text. Prof. van Zandvoort leads microscopy-focused research within IMCAR, utilizing two-photon endoscopy systems and multiphoton imaging platforms. His collaborative network spans 17 institutions across Europe, with frequent co-authorship on projects involving tissue-engineered heart valves, placental microvasculature quantification, and super-resolution pathology profiling.